Skip to Main Content

Author Details

Alfredo Hidalgo-Miranda
1998
115
33
PMIDPaper TitleJournal TitlePublished Year
36851588SARS-CoV-2 Genome Variations in Viral Shedding of an Immunocompromised Patient with Non-Hodgkin's Lymphoma.2023
37342324The current advances of lncRNAs in breast cancer immunobiology research.2023
36831031Conversion of M1 Macrophages to Foam Cells: Transcriptome Differences Determined by Sex.2023
37260772LINC00426 is a potential immune phenotype-related biomarker and an overall survival predictor in PAM50 luminal B breast cancer.2023
36982511MiRNAs in Hematopoiesis and Acute Lymphoblastic Leukemia.2023
35027672Cell-free DNA analysis in current cancer clinical trials: a review.British Journal of Cancer2022
36359853Breast Cancer Cells Reprogram the Oncogenic lncRNAs/mRNAs Coexpression Networks in Three-Dimensional Microenvironment.Cells2022
36096296Hepatic mir-122-3p, mir-140-5p and mir-148b-5p expressions are correlated with cytokeratin-18 serum levels in MAFLD.Annals of Hepatology2022
35745482Analytical Performances of the COVISTIX Antigen Rapid Test for SARS-CoV-2 Detection in an Unselected Population (All-Comers).Pathogens2022
35626094Three-Dimensional Organotypic Cultures Reshape the microRNAs Transcriptional Program in Breast Cancer Cells.Cancers (Basel)2022
35685921Low Prevalence of Fusion Gene in a Hispanic Population.Frontiers in Pediatrics2022
35413231Gene expression profiles and cytokine environments determine the in vitro proliferation and expansion capacities of human hematopoietic stem and progenitor cells.Hematology2022
35719952Underexpression of in -Positive Cases Is Associated With Poor Prognosis in Children With B-Cell Precursor Acute Lymphoblastic Leukemia.Frontiers in Oncology2022
36419901NK cells with decreased expression of multiple activating receptors is a dominant phenotype in pediatric patients with acute lymphoblastic leukemia.Frontiers in Oncology2022
36187646Persistently high incidence rates of childhood acute leukemias from 2010 to 2017 in Mexico City: A population study from the MIGICCL.Frontiers in Public Health2022
36460546Cancer Genomics.2022
35336952Early Genomic, Epidemiological, and Clinical Description of the SARS-CoV-2 Omicron Variant in Mexico City.Viruses2022
34804964Association Analysis Between the Functional Single Nucleotide Variants in miR-146a, miR-196a-2, miR-499a, and miR-612 With Acute Lymphoblastic Leukemia.Frontiers in Oncology2021
33492282Coexpression of Smac/DIABLO and Estrogen Receptor in breast cancer.Cancer Biomarkers2021
33912452LINC00460 Is a Dual Biomarker That Acts as a Predictor for Increased Prognosis in Basal-Like Breast Cancer and Potentially Regulates Immunogenic and Differentiation-Related Genes.Frontiers in Oncology2021
33854067Comprehensive omic characterization of breast cancer in Mexican-Hispanic women.Nature Communications2021
33581365Saliva is a reliable and accessible source for the detection of SARS-CoV-2.International Journal of Infectious Diseases2021
33517184Challenges of diagnostic genomics in Latin America.Current Opinion in Genetics and Development2021
33986977Dysregulation of miR-381-3p and miR-23b-3p in skeletal muscle could be a possible estimator of early post-mortem interval in rats.PeerJ2021
33936570Quantitative proteomic analysis of extracellular vesicle subgroups isolated by an optimized method combining polymer-based precipitation and size exclusion chromatography.Journal of Extracellular Vesicles2021
34298989Mitochondrial Heteroplasmy Shifting as a Potential Biomarker of Cancer Progression.International Journal of Molecular Sciences2021
33290991Promising genes and variants to reduce chemotherapy adverse effects in acute lymphoblastic leukemia.Translational Oncology2021
34867958Mechanisms of Immunosuppressive Tumor Evasion: Focus on Acute Lymphoblastic Leukemia.Frontiers in Immunology2021
34448936Emergence and spread of the potential variant of interest (VOI) B.1.1.519 of SARS-CoV-2 predominantly present in Mexico.Archives of Virology2021
34898237SARS-CoV-2 Infection Rate in Patients With Cancer and Health Care Workers in a Chemoradiotherapy Unit During the Pandemic: A Prospective Cohort in Mexico.JCO Global Oncology2021
34551335SARS-CoV-2 positivity rates in asymptomatic workers at a cancer referral center in Mexico City: A prospective observational study in the context of adapting hospitals back to regular practice.American Journal of Infection Control2021
32839509FAM83H-AS1 is a potential modulator of cancer driver genes across different tumors and a prognostic marker for ER/PRâ¿¿+â¿¿BRCA patients.Scientific Reports2020
32183133Transcriptome Analysis Identifies LINC00152 as a Biomarker of Early Relapse and Mortality in Acute Lymphoblastic Leukemia.Genes2020
33194675Mitochondrial DNA Mutation Analysis in Breast Cancer: Shifting From Germline Heteroplasmy Toward Homoplasmy in Tumors.Frontiers in Oncology2020
32753692A lncRNA landscape in breast cancer reveals a potential role for AC009283.1 in proliferation and apoptosis in HER2-enriched subtype.Scientific Reports2020
32806777MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast Cancer.Cancers2020
33072605Genotype-Environment Interaction Analysis of NQO1, CYP2E1, and NAT2 Polymorphisms and the Risk of Childhood Acute Lymphoblastic Leukemia: A Report From the Mexican Interinstitutional Group for the Identification of the Causes of Childhood Leukemia.Frontiers in Oncology2020
31322273Growth inhibition and transcriptional effects of ribavirin in lymphoma.Oncology Reports2019
30648789Expression of long non-coding RNA ENSG00000226738 (LncKLHDC7B) is enriched in the immunomodulatory triple-negative breast cancer subtype and its alteration promotes cell migration, invasion, and resistance to cell death.Molecular Oncology2019
30630528Population and breast cancer patients' analysis reveals the diversity of genomic variation of the BRCA genes in the Mexican population.Human Genomics2019
30621578A panel of 32 AIMs suitable for population stratification correction and global ancestry estimation in Mexican mestizos.BMC Genetics2019
30705400WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer.Oncogene2019
31541186The Human Papillomavirus (HPV) E1 protein regulates the expression of cellular genes involved in immune response.Scientific Reports2019
30744139Long Non-Coding RNA and Acute Leukemia.International Journal of Molecular Sciences2019
30721448Wide Profiling of Circulating MicroRNAs in Spinocerebellar Ataxia Type 7.Molecular Neurobiology2019
29701016Functional Integrity and Gene Expression Profiles of Human Cord Blood-Derived Hematopoietic Stem and Progenitor Cells Generated In Vitro.Stem cells translational medicine2018
29983835Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.Clinical Epigenetics2018
30115973Loss of function of miR-342-3p results in MCT1 over-expression and contributes to oncogenic metabolic reprogramming in triple negative breast cancer.Scientific Reports2018
30015870Overview of mitochondrial germline variants and mutations in human disease: Focus on breast cancer (Review).International Journal of Oncology2018
30089516Correction to: Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.Clinical Epigenetics2018
  • 1 - 50 of 115

Recommended Authors

Collaborators

Co-authored papers 23
Co-authored papers 23
Co-authored papers 13
Co-authored papers 12
Co-authored papers 11
Co-authored papers 9
Co-authored papers 8
Co-authored papers 8
Co-authored papers 7
Co-authored papers 7
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 6
Co-authored papers 6
Co-authored papers 6
Broad Institute
Co-authored papers 5
Vanderbilt-Ingram Cancer Center, Vanderbilt University
Co-authored papers 5
Co-authored papers 5
Broad Institute of MIT and Harvard
Co-authored papers 5
Broad Institute of MIT and Harvard
Co-authored papers 5
Co-authored papers 4
The Broad Institute of Harvard and MIT
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Co-authored papers 3
Cystic Fibrosis Foundation
Co-authored papers 3
Broad Institute of MIT and Harvard
Co-authored papers 3
Broad Institute of Harvard and MIT
Co-authored papers 3
The Broad Institute of Harvard and MIT
Co-authored papers 3